// App-Quantinova.ai

: Treatment Patterns and Prior Medication Usage Before Dupilumab Treatment Initiation in Patients With AD: Real-World Data From GLOBOSTAD

Researchers

Presenter

  • Silvia M. Ferrucci

Principal Investigators

  • M. Rossi

  • Daria S. Fomina

  • Hilde Lapeere

  • Wen-Hung Chung

  • Thrasyvoulos Tzellos

  • Anne-Claire Fougerousse

  • Minzhi Liu

  • Marius Ardeleanu

  • Daniel Richman

Medical Centers

  • NICU, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Universita degli Studi di Milano, Milan, Italy

  • University of Brescia, Brescia, Italy

  • City Clinical Hospital No.

  • , Moscow, Russian Federation

  • The First Sechenov Moscow State Medical University under Ministry of Health of the Russian Federation , Moscow, Russian Federation

  • Ghent University Hospital, Ghent, Belgium

  • Chang Gung Memorial Hospital, Taipei, Taiwan

  • Institute of Clinical Medicine, UiTthe Arctic University of Norway, Tromso, Norway

  • ResoEczema, Paris, France

  • Tigermed-BDM Inc., Somerset, NJ, USA

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY

  • Sanofi Genzyme, Cambridge, USA

Locations

  • Russia

  • United States

  • France

  • Norway

  • Italy

  • United Kingdom

  • Taiwan

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Dupilumab

Outcome

  • N/A

Study Design

  • Non Interventional

  • Multinational

  • Multicenteric

Phase

  • N/A

Study Id's

  • NCT03992417

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved